Flanimus

Breathalyzer Test for Diagnosing Coronavirus

Health Tech & Life Sciences
Active
Pre-Funding Rehovot Founded 2020
Total raised
Stage
Pre-Funding
Founded
2020
Headcount
6
HQ
Rehovot
Sector
Health Tech & Life Sciences

About

Flanimus is a simple, one-minute breathalyzer test for diagnosing the coronavirus at the cost of three dollars per test. The Flanimus test can be performed at any location and by any operator, without the need for trained staff or dedicated labs. The device comprises two main parts: a disposable capsule with a chip inside and a spectrometer. After breathing into the capsule, it is inserted into the spectrometer, and the spectral signature of the virus is detected using proprietary software.

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesDiagnostics DevicesDigital HealthcareDigital Medical Diagnostics
Technologies
Materials & SubstancesNanomaterialsSemiconductors & ElectronicsPlatforms & InterfacesSoftware
Target customers
Travel & Tourism
Business model
B2B

Tags

software-developmentdigital-healthcarediagnosticsairportsmedical-technologiesmedical-devices